Rihanna's Story of Treatment on a Clinical Trial with Larotrectinib

Hear the story of Rihanna Plaza, who was on a clinical trial with larotrectinib. Larotrectinib is the first targeted therapy to be FDA approved based solely on its effect on a specific genetic change in a tumor, regardless of where in the body the tumor originated.